EP905 Ovarian cancer treatment in the elderly

Introduction/Background Treatment of elderly patients with neoplasia is challenging due to the frailty of the patients, existing comorbidities and increased number of concomitant medications. In addition, elderly patients are usually underrepresented in clinical trials. Age is a known prognostic factor in ovarian cancer but optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced stage ovarian cancer patients older than 75 years of age.Methodology Medical records of women with high grade serous and endometrial ovarian cancer, stage III and IV, treated at Alexandra Hospital from 2011 to 2016 were retrospectively identified. Clinicopathological data, treatment and survival data were analyzed. Kaplan-Meier Survival curves were generated using IBM SPSS version 20; survival differences were estimated using the long-rank test …